Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NTEG- Bloodless Glucose Monitor -- Ignore unavailable to you. Want to Upgrade?

To: nestegg who wrote (150)	6/10/1998 5:40:00 PM
From: xamir	Read Replies (1) \| Respond to of 176

Can anybody comment, when NTEG suppose to get approvel from FDA? thanks alex

To: nestegg who wrote (150)	6/11/1998 10:53:00 AM
From: BitWizrd	Read Replies (2) \| Respond to of 176

From Volpe: "Key Features and Advantages of the LifeGuide System: * Potential for increased accuracy due to direct sampling of ISF * Bloodless and more convenient compared to current methods. * Sampling flexibility; unit is designed to be used on skin almost anywhere on the body. * Faster results compared to some other non-invasive technologies. * Easier to use when compared to current blood based systems. "Problems with the Lifeguard System: * Method is not completely noninvasive: - We have experienced pain while using a prototype meter; - May require two sticks for adequate ISF sample. * Possible contamination of ISF sample by blood, causing inaccurate readings: - We have observed sample contamination from blood while using a prototype meter. * Device is very large and not very portable. * Price of disposable man be expensive compared to current blood based systems. "Possible pricing at the retail level will be $250 to 350 for the meter and around $0.80 per consumable per test." My read: Users pay more, lug a heavier meter, stick themselves as much as twice as often, for BG readings that are "potentially" more accurate, but only if I can avoid contaminating the sample. There must be something better out there in development.